CO5011045A1 - Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos - Google Patents

Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos

Info

Publication number
CO5011045A1
CO5011045A1 CO99022015A CO99022015A CO5011045A1 CO 5011045 A1 CO5011045 A1 CO 5011045A1 CO 99022015 A CO99022015 A CO 99022015A CO 99022015 A CO99022015 A CO 99022015A CO 5011045 A1 CO5011045 A1 CO 5011045A1
Authority
CO
Colombia
Prior art keywords
tienilazolilalcoxietanaminas
medications
preparation
application
nitrogen
Prior art date
Application number
CO99022015A
Other languages
English (en)
Inventor
Ramon Merce-Vidal
Andaluz-Mata Blas
Constansa Jordi Frigola
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of CO5011045A1 publication Critical patent/CO5011045A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un derivado de tienilazolilalcoxietanamina defórmula general (I):en la cual R1 es un átomo de hidrógeno, un halógeno o un radical alquilo de 1 a 4 átomos de carbono;R2 , R3 y R4 representan, independientemente, un átomo de hidrógeno o un radical alquilo de 1 a 4 átomos de carbono; yAz representa un heterociclo aromático nitrogenado de 5 miembros, N-metilsustituido, que contiene de uno a tres átomos de nitrógeno, de fórmula general (III)donde Z1, Z2 y Z3, independientemente, representan un átomo de nitrógeno o CH, con la condición de que, al menos, uno de Z1 , Z2 o Z3 es CH; y sus sales fisiológicamente aceptables.
CO99022015A 1998-04-15 1999-04-14 Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos CO5011045A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009800793A ES2150353B1 (es) 1998-04-15 1998-04-15 Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.

Publications (1)

Publication Number Publication Date
CO5011045A1 true CO5011045A1 (es) 2001-02-28

Family

ID=8303465

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99022015A CO5011045A1 (es) 1998-04-15 1999-04-14 Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos

Country Status (31)

Country Link
US (3) US6410582B1 (es)
EP (1) EP1072266B8 (es)
JP (1) JP2002511412A (es)
KR (1) KR100523366B1 (es)
CN (1) CN1189170C (es)
AR (1) AR016210A1 (es)
AT (1) ATE302604T1 (es)
AU (1) AU754705B2 (es)
BG (1) BG64891B1 (es)
BR (1) BR9910124A (es)
CA (1) CA2328878A1 (es)
CO (1) CO5011045A1 (es)
CU (1) CU22960A3 (es)
CZ (1) CZ298222B6 (es)
EE (1) EE04739B1 (es)
ES (1) ES2150353B1 (es)
GE (1) GEP20032913B (es)
HU (1) HUP0102585A3 (es)
IS (1) IS5662A (es)
LT (1) LT4830B (es)
LV (1) LV12624B (es)
NO (1) NO320313B1 (es)
NZ (1) NZ507573A (es)
PL (1) PL343512A1 (es)
RO (1) RO121690B1 (es)
RU (1) RU2213743C2 (es)
SI (1) SI20473A (es)
SK (1) SK285039B6 (es)
TW (1) TW528756B (es)
UA (1) UA58589C2 (es)
WO (1) WO1999052525A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) * 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.
US6432954B1 (en) * 2000-07-14 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
ES2174756B2 (es) * 2001-04-06 2003-11-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.
ES2180449B1 (es) * 2001-07-06 2004-01-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
CL2004001034A1 (es) 2003-05-14 2005-03-28 Teijin Pharma Ltd Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
WO2006010627A1 (en) * 2004-07-30 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1632227A1 (en) * 2004-09-07 2006-03-08 Laboratorios del Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
EP1671968A1 (en) 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
WO2006063860A2 (en) * 2004-12-17 2006-06-22 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
ES2303795B1 (es) * 2004-12-27 2009-06-12 Laboratorios Del Dr. Esteve, S.A. Procedimiento para obtener enantiomeros de tienilazolilalcoxietanaminas.
EP1674465A1 (en) 2004-12-27 2006-06-28 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
WO2006069767A1 (en) * 2004-12-27 2006-07-06 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US20070149590A1 (en) * 2005-08-05 2007-06-28 Garcia Francisco J L Controlled release dosage form of pirazole compounds
EP1820502A1 (en) 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
CN102432845B (zh) * 2011-08-22 2013-03-13 电子科技大学 聚3,4-双乙基羟基噻吩气敏材料及其制备方法
EP3233805B1 (en) 2014-12-15 2019-02-06 Esteve Pharmaceuticals, S.A. Methyl-1h-pyrazole-alkylamine compounds having multimodal activity against pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613720B1 (fr) * 1987-04-10 1990-01-19 Esteve Labor Dr Derives d'aryl-heteroaryl carbinols avec activite analgesique
ES2150353B1 (es) 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.

Also Published As

Publication number Publication date
US20040162324A1 (en) 2004-08-19
CZ20003764A3 (en) 2001-05-16
LT2000097A (en) 2001-03-26
KR100523366B1 (ko) 2005-10-20
CN1189170C (zh) 2005-02-16
WO1999052525A1 (es) 1999-10-21
EE04739B1 (et) 2006-12-15
UA58589C2 (uk) 2003-08-15
BG64891B1 (bg) 2006-08-31
AU3148399A (en) 1999-11-01
US7129361B2 (en) 2006-10-31
US6410582B1 (en) 2002-06-25
NO20005146D0 (no) 2000-10-13
CA2328878A1 (en) 1999-10-21
NO20005146L (no) 2000-12-14
CN1303283A (zh) 2001-07-11
CZ298222B6 (cs) 2007-07-25
BG104853A (en) 2001-04-30
ES2150353A1 (es) 2000-11-16
ATE302604T1 (de) 2005-09-15
EE200000596A (et) 2002-06-17
LV12624A (lv) 2001-03-20
PL343512A1 (en) 2001-08-27
AU754705B2 (en) 2002-11-21
TW528756B (en) 2003-04-21
SK15282000A3 (sk) 2001-12-03
HUP0102585A2 (hu) 2001-12-28
CU22960A3 (es) 2004-06-21
BR9910124A (pt) 2001-01-09
EP1072266B8 (en) 2006-10-18
GEP20032913B (en) 2003-03-25
RU2213743C2 (ru) 2003-10-10
US20020188017A1 (en) 2002-12-12
KR20010042739A (ko) 2001-05-25
NZ507573A (en) 2002-07-26
EP1072266B1 (en) 2005-08-24
ES2150353B1 (es) 2001-07-01
SK285039B6 (sk) 2006-05-04
NO320313B1 (no) 2005-11-21
LT4830B (lt) 2001-08-27
SI20473A (sl) 2001-08-31
HUP0102585A3 (en) 2002-04-29
RO121690B1 (ro) 2008-02-28
JP2002511412A (ja) 2002-04-16
LV12624B (lv) 2001-09-20
AR016210A1 (es) 2001-06-20
IS5662A (is) 2000-10-13
EP1072266A1 (en) 2001-01-31

Similar Documents

Publication Publication Date Title
CO5011045A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
NO20013379L (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
MX9203122A (es) Compuestos analogos de distamicina a y composiciones farmaceuticas que los contienen.
DK0625977T3 (da) Piperazinderivater som 5-1A-antagonister
DK1008592T3 (da) Cykliske amidderivater, som inhiberer cathepsin K
ES2192031T3 (es) Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2177058T3 (es) Compuestos eter piperidinilaminometil trifluorometil ciclicos como antagonistas de la sustancia p.
ES2142773A1 (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
ATE497948T1 (de) Bicyclische verbindungen
DK0916651T3 (da) Phenylalkylcarboxylsyrederivater
ES2162404T3 (es) Nuevos derivados del indol y del indazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
EP1671957A4 (en) THIADIAZOLINDERIVATE
AR010098A1 (es) COMPOSICION Y PROCEDIMIENTO PARA LA DEFORMACION PERMANENTE DEL CABELLO, Y PROCEDIMIENTO DE PREPARACIoN DE DICHA COMPOSICION
DK0947504T3 (da) 16-en-vitamin D-derivater
NO961236L (no) Pyrrolodiazin-derivater som stabilisatorer for klorholdige polymerisater
AR245699A1 (es) Compuestos derivados de n'-alquil-n,n'-diacilhidrazinas insecticidamente activos y composicion que los comprende.
ES2188481T3 (es) Derivados de polinalbufina.
DE69416683D1 (de) Benzolactam-derivate
ES2112489T3 (es) Derivados carboxilato que presentan una actividad inhibidora de la fosfolipasa a2.
CA2225780A1 (fr) Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2190781T3 (es) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano.
AR023528A1 (es) Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica
ES2192830T3 (es) Derivados de benzo(b)pirano utiles como agentes externos para la piel.
DE60221250D1 (de) Bis(5-aryl-2-pyridyl)derivate